AVXL Anavex Life Sciences Corp

Price (delayed)

$2.815

Market cap

$260.87M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.46

Enterprise value

$129.12M

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8

Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, ...

Highlights
AVXL's quick ratio has soared by 125% YoY and by 80% QoQ
Anavex Life Sciences's equity has increased by 33% QoQ and by 14% YoY

Key stats

What are the main financial stats of AVXL

AVXL stock price

How has the Anavex Life Sciences stock price performed over time
Intraday
6.43%
1 week
-4.25%
1 month
-17.45%
1 year
-63.54%
YTD
-20.93%
QTD
-8.31%

Financial performance

How have Anavex Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$44.6M
Net income
-$39.95M
Gross margin
N/A
Net margin
N/A
AVXL's operating income is up by 19% year-on-year and by 13% since the previous quarter
Anavex Life Sciences's net income has increased by 14% YoY and by 14% QoQ

Price vs fundamentals

How does AVXL's price correlate with its fundamentals

Growth

What is Anavex Life Sciences's growth rate over time

Valuation

What is Anavex Life Sciences stock price valuation
P/E
N/A
P/B
1.99
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 16% YoY and by 15% QoQ
The stock's price to book (P/B) is 72% less than its last 4 quarters average of 6.6 and 69% less than its 5-year quarterly average of 6.0
Anavex Life Sciences's equity has increased by 33% QoQ and by 14% YoY

Efficiency

How efficient is Anavex Life Sciences business performance
The ROE has grown by 17% from the previous quarter but it has contracted by 3.5% YoY
AVXL's return on assets is up by 16% since the previous quarter but it is down by 2.6% year-on-year

Dividends

What is AVXL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVXL.

Financial health

How did Anavex Life Sciences financials performed over time
AVXL's quick ratio has soared by 125% YoY and by 80% QoQ
The company's current ratio has surged by 121% YoY and by 80% QoQ
The debt is 100% smaller than the equity
Anavex Life Sciences's equity has increased by 33% QoQ and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.